ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) rose 13% during trading on Wednesday . The stock traded as high as $0.85 and last traded at $0.80. Approximately 7,468 shares traded hands during trading, an increase of 191% from the average daily volume of 2,563 shares. The stock had previously closed at $0.71.
ZIVO Bioscience Stock Performance
The firm's 50 day simple moving average is $0.73 and its 200 day simple moving average is $0.78.
Get ZIVO Bioscience alerts:Institutional Inflows and Outflows
A hedge fund recently raised its stake in ZIVO Bioscience stock. Warberg Asset Management LLC boosted its position in shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,654 shares of the company's stock after buying an additional 69,034 shares during the quarter. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 as of its most recent filing with the Securities & Exchange Commission.
About ZIVO Bioscience
(Get Rating)
ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.
Further Reading
- Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
- Roblox Gains Traction With Metaverse, Shares Pop
- GXO Logistics Manages Another Buying Opportunity
- Arista Networks In Buy Range After Topping Q4 Views
- Analysts Like The Flavor Of Restaurant Brands International
- What is Consumer Discretionary?
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.